Were Regencell's Boilerplate Risk Warnings Adequate? Lawsuit Alleges $14 Billion Company Used Generic Volatility Disclaimers to Mask Specific Market Manipulation Vulnerability Were Regencell's Boilerplate Risk Warnings Adequate? Lawsuit Alleges $14 Billion Co…
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP examines the adequacy of Regencell Bioscience Holdings Limited's (NASDAQ: RGC) risk disclosures in connection with a securities c…